The humoral immune response against SE and PPV developed by ERYSENG® PARVO/LEPTO was faster, higher and lasted longer than the response obtained with vaccine A. This situation guarantees better protection for sows during the gestation period and would prevent the presence of negative sub-populations susceptible to suffering from clinical diseases with the consequent associated reproduction losses.
This website uses its own cookies and those of third parties to improve our services and navigation. If you continue browsing, we understand that you accept our use of these cookies. For more information,
see our cookies policy.I accept